from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3857c/-

LFCtreatmentdescriptionclass of inhibitor

0.416

Amikacinug/mL Amikacintranslation

-0.183

Cap5-10ug/mL Capreomycintranslation

0.181

Rox10-50 ug/mL Roxithromycintranslation

0.277

SM2-5 ug/mL Streptomycintranslation

0.354

Tet5-10 ug/mL Tetracyclinetranslation

-1.079

Rif0.2-5ug/mL Rifampicintranscription

-0.079

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.280

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.871

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.570

CPZ10-50 ug/mL Chlorpromazinerespiration

0.469

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.129

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.885

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.742

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.294

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.016

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.474

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.507

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.971

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.204

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.671

KCN5-20 ug/mL Potassium cyaniderespiration

1.354

NaN30.2-2 mM Sodium aziderespiration

-0.881

Nigericin50 uM Nigericinrespiration

0.339

TRC10-150 ug/mL Triclosanrespiration

-0.102

TRZ10-25 ug/mL Thioridazinerespiration

0.930

Valinomycin0.5-10 uM Valinomycinrespiration

-0.307

ZnSO42 mM ZnSO4respiration

-0.065

menadione6-10 ug/mL Menadionerespiration

-0.285

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.606

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.933

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.296

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.517

NRP_1Non-replicating persistence stage 1dosRassociated

0.042

Amp0.2mg/mL AmpicillincellWall

-0.142

Cephalexin20-100 ug/mL CephalexincellWall

-0.512

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.634

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.548

EMB10-20 ug/mL EthambutolcellWall

0.261

Eta12-40 ug/mL EthionamidecellWall

0.765

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.291

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.347

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.477

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.741

BZA0.12 mg/mL BenzamidearomaticAmides

0.234

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.316

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.084

H2O24 mM hydrogen peroxideDNAdamaging

-0.968

Levo10 ug/mL LevofloxacinDNAdamaging

-0.699

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.491

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.512

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.557

UVUV-irradiationDNAdamaging

0.105

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.332

Antimycin12.5-50 ug/mL Antimycin A?

-0.490

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.728

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.665

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.753

PA8240.2-2 ug/mL PA-824?

2.319

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.399

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.099

Verapamil50 uM Verapamil?

-0.766

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.582

methoxatin10-20 ug/mL Methoxatin?